Interagro (UK) Ltd

Interagro (UK) Limited was a British specialist formulator and marketer of in-can agricultural adjuvants and plant biostimulants, founded by Mike Roche and trading since 1994. These products are not pesticides themselves. They are spray-tank additives and plant-health inputs that make crop protection chemistry work better: water conditioners, pH buffers, compatibility agents, drift retardants, activator oils and spreaders, pod sealants, soil conditioners and stabilisers, and amino-acid, peptide and seaweed biostimulants.

Its flagship brands, Kantor, Toil, Backrow, Spur, Sorrento, Newton and Bridgeway, built a reputation with UK agronomists. Out-licensing through distributors such as Cérience in France took its products to 27 country markets.

In April 2023 Japan's Nihon Nohyaku bought the company through Nichino Europe, its first acquisition in Europe, to move beyond synthetic agrochemicals. From April 2025 the business operated as part of Nichino Europe. The legal entity entered solvent liquidation in December 2025, while its portfolio now acts as Nichino's direct-to-market platform in the UK and Ireland.

Company's own description

Interagro's legacy website describes the company as a results-driven adjuvant and biostimulant business. It says the company aims to improve the performance of crop protection inputs and improve plant health. The range covers adjuvants, water conditioners, soil care and anti-drift agents, plus biostimulants intended to reduce abiotic stress so crops can reach their genetic yield potential (interagro.co.uk, accessed Oct 2026).

At acquisition, Nichino described Interagro as a leading manufacturer of in-can adjuvants and biostimulants operating in 27 countries. It said the full portfolio covered water conditioners, pod stickers, specialist anti-drift agents, and foliar and seed-treatment biostimulants (Nichino Europe release, 3 April 2023).

No annual-report "business description" was retrieved. The strategic report in the filed group accounts would contain one but was not accessible.

Independent characterisation

Business model. Interagro was an asset-light, IP- and registration-led specialty formulator. Its value came from four things:

• Proprietary formulations and trademarks. For example, Cérience's French label for Cantor/Pentra names the products as registered trademarks and property of Interagro UK Ltd.

• Regulatory approvals. Adjuvants in the UK need Chemicals Regulation Division (CRD) approval, and in France an AMM (e.g., AMM no. 2090013 for Cantor/Pentra, an ethoxylated soybean oil EC at 790 g/L).

• Field-trial evidence, including University of Nottingham glasshouse work in 2022 on Newton and Bridgeway.

• Agronomist-facing technical marketing.

The SIC code is "manufacture of other chemical products". However, the 2023 headcount of 13 people strongly suggests manufacturing was toll-formulated by third parties rather than run in owned plants. This is an inference, not a disclosed fact.

Revenue model. Revenue was almost entirely product sales, in two channels:

1. UK distribution through agricultural merchants and distributors, with demand created by agronomists.

2. International out-licensing and supply of branded or private-label products to crop protection manufacturers, co-operatives and distributors.

The international page notes the same products are sold under different trade names in different markets. For example, the pod sealant Iskay is also sold as Flexi, Latiss or Vice, and the Kantor formulation appears in France as Cantor/Pentra via Cérience. There is no evidence of subscription, service or licensing-fee revenue. A royalty or brand-licence element in out-licensing deals is possible but not disclosed.

Value-chain position. The company sat between commodity surfactant and oil suppliers upstream and distributors and agronomists downstream. Its added value lay in formulation, registration, claims support and brand.

Customers. Its direct customers were distributors, merchants, co-operatives and crop protection manufacturers. End users were arable farmers (cereals, oilseed rape, pulses), potato growers, horticulture and fruit producers, and organic growers (Bridgeway carries Soil Association and Organic Farmers & Growers certification).

End-markets. Agricultural adjuvants and biostimulants in the UK, the EU (notably France and the Netherlands), Eastern Europe, North Africa and the Middle East.

Post-2023 role. Within Nichino, Interagro gave the group a route to market in the UK and Ireland. From January 2025 Nichino began selling its own pyraflufen-ethyl products (GOZAI, KABUKI) through the Interagro platform, with flutolanil-based products following in summer 2025 (Nichino Europe press release, 2025). The business therefore changed from a stand-alone adjuvant house into the commercial front end of a Japanese research-based agrochemical company in Britain and Ireland.

Pre-acquisition strategy (founder / Ralph era)

Trade-press statements set out a consistent thesis. Fewer available crop protection actives, rising resistance and tighter regulation make it more valuable to get more performance from existing chemistry. Adjuvants and biostimulants were the means to do that.

Management tied this to four strategic thrusts:

1. Product discovery and EU launches. The Regulatory Manager hire was explicitly linked to expanding product discovery and launches into EU markets.

2. International growth. This ran through the Netherlands hub (c.2019) and an EU commercial technical manager focused on biologicals (2020).

3. Biostimulants. The company moved into biostimulants (Newton, Bridgeway) backed by university data (2022).

4. Environmental positioning. Products were framed as tools against spray drift, run-off and soil erosion.

At acquisition the company restated its commitment to R&D and technology with a strong environmental focus.

Nichino-era strategy (2023 to present)

Medium-term financial targets. None are disclosed for Interagro. At parent level, Nihon Nohyaku guides FY2027 (year to March 2027) to net sales of JPY 116.0bn (+3.7%), operating profit of JPY 11.5bn (+5.7%) and net profit of JPY 7.4bn (+2.4%), with a dividend of JPY 38 (envalith; FilingReader, May 2026).

ESG commitments. No Interagro-specific quantified ESG targets were found.

Pricing is not publicly disclosed for any product. Launch years are given only where verifiable.

Interagro (UK) Limited — reporting-period register

Group accounts exist at Companies House but could not be retrieved, and no secondary source with reliable figures was found. Rather than estimate, this section records the filing periods and uses ultimate-parent data for context.

Interagro filed group accounts rather than simply relying on small-company filing exemptions. That is consistent with a group above the small-group thresholds or one choosing to consolidate, but it does not establish revenue scale.

The declaration of solvency filed in January 2026 confirms that the directors swore the company could pay its debts in full within 12 months of the winding-up resolution. That is the strongest verifiable statement about Interagro's financial position in the public record.

Ultimate parent context — Nihon Nohyaku Co., Ltd

Sources: stockanalysis.com (TSE filings); envalith.com; FilingReader (TSE Tanshin summaries).

Revenue CAGR FY2022–FY2026 was about 8.1% a year (computed).

Parent commentary.

Growth and margins: Nihon Nohyaku's sales rose 24.6% in FY2023 on price and volume. They were roughly flat in FY2024–FY2025, then reached a record JPY 111.8bn in FY2026 (+11.9%). FilingReader attributes the FY2026 growth to strong North American insecticide demand after early pest outbreaks in California, one-off compensation for US registration data use, and strong European affiliates. Gross margin widened from 29.0% (FY2024) to 34.0% (FY2026).

Profit volatility: Net income halved in FY2025 because of JPY 4,672m of extraordinary losses. In the same year goodwill fell from JPY 2,645m to nil. The data reviewed does not attribute that write-down to any specific acquisition, so it should not be assumed to relate to Interagro.

Goodwill: Goodwill amortisation in the Agrochemicals segment was JPY 238m in FY2025 and JPY 103m in FY2026.

Working capital and leverage: Working capital consumed cash through FY2022–FY2024, and net debt peaked at JPY 19.3bn in FY2024. Deleveraging followed as inventories normalised.

Capital returns: The FY2026 total dividend was JPY 36 per share, raised from the earlier JPY 27 forecast. The FY2027 forecast is JPY 38. The payout ratio is about 39%.

Relevance to Interagro: These figures show the financial capacity behind the Interagro business. They say nothing about Interagro's own profitability.

Guidance

There is no guidance for Interagro, which is in liquidation. The parent guides FY2027 (to March 2027) to net sales of JPY 116.0bn (+3.7%), operating profit of JPY 11.5bn (+5.7%), net profit of JPY 7.4bn (+2.4%) and a dividend of JPY 38.

Bull case (for the Interagro franchise inside Nichino)

1. Proven distribution asset. The platform already carried Nichino's pyraflufen-ethyl and flutolanil launches in 2025. Each new Nichino active can be paired with Kantor or Spur-type adjuvants, raising revenue per hectare.

2. Structural tailwind. Fewer actives and more resistance increase the economic value of adjuvants. The global market is about USD 4.2bn growing 5–7%, with Europe projected fastest-growing.

3. Balance-sheet backing. The parent's FY2026 record sales, 54.9% equity ratio and falling net debt (JPY 8.3bn) provide funding for registrations and the potato biostimulant pipeline.

Bear case

1. Human-capital drain. The MD, marketing lead and technical lead all left for direct competitors in 2024–25, taking agronomist relationships that were central to a 13-person specialist.

2. Brand retirement. Folding Interagro into the Nichino brand and liquidating the entity risks eroding recognition of Kantor and Toil just as distributor own-brands and De Sangosse compete for the same recommendations.

3. Farm-economy pressure. Adjuvants and biostimulants are discretionary. Price collapses (e.g., 2025 potatoes) and margin pressure on UK arable farms could cut spend.

Key catalysts and monitorables (next 12 months)

• Confirmation of Interagro (UK) Limited's dissolution at Companies House, and any final liquidator returns.

• Transfer of registrations and trademarks (e.g., French AMM 2090013, UK CRD approvals) to Nichino Europe.

• UK/IE launches of the planned pyraflufen-ethyl solutions and the root-and-bulb biostimulant.

• Nichino Europe's own Companies House accounts (CH 06354832), which now carry the combined business.

• Parent H1 FY2027 results (expected around November 2026), especially European affiliate commentary.

• Competitive moves by De Sangosse and Origin's BAM unit in UK adjuvants.

Analyst verdict

Interagro (UK) Limited is not a public company, and as a legal entity it is nearing its end. After almost three decades as an independent British adjuvant and biostimulant specialist, it was bought outright by Nichino Europe on 3 April 2023. It was merged into Nichino's operations and brand on 1 April 2025, and placed into a solvent members' voluntary liquidation in December 2025 and January 2026.

Any assessment therefore has to separate the shell from the franchise. The shell has no investment case: it has no traded securities, it is being wound up, and the declaration of solvency suggests creditors will be paid in full. The franchise is the asset that matters. It comprises the Kantor, Toil, Spur, Sorrento, Backrow, Newton and Bridgeway brands, the registrations and organic certifications, the out-licensing relationships across 27 countries, and the UK agronomist following.

Strategically, the acquisition makes sense for Nihon Nohyaku. It bought a ready-made route to market in the UK and Ireland, which it used within 21 months to launch its own actives. It also gained a credible move into adjuvants and biostimulants, consistent with its stated aim of going beyond synthetic chemistry.

Execution risk is concentrated in people and brand. The 2024–25 departures of the managing director and senior commercial and technical staff to Origin and De Sangosse are the most material negative developments in the record. They hit a business whose value lay largely in relationships and know-how.

Financial transparency is poor. Interagro's own accounts could not be verified here and should be obtained directly from Companies House before any valuation or credit work. In summary, Interagro is best understood as a small, strategically useful bolt-on now embedded in a profitable, moderately leveraged Japanese mid-cap. Exposure to it is available only indirectly, through Nihon Nohyaku (TSE 4997), where it is immaterial to group results.

Sources

• Companies House filing history, Interagro (UK) Limited (02849808): find-and-update.company-information.service.gov.uk/company/02849808/filing-history

• companiesintheuk.co.uk – Interagro (UK) Limited profile (former name; liquidation filings)

• tinytax.co.uk – Interagro (UK) Limited (incorporation date, SIC)

• Nichino Europe – Acquisition notice, 3 April 2023: nichino-europe.com/files/d0da8f-ia.pdf

• Nichino Europe – UK & Ireland press release (2025): nichino-europe.com/files/5a010c-neu-uk-ire.pdf

• Nichino Europe – International adjuvants and biostimulants page: nichino-europe.com/about/international/

• AgribusinessGlobal – Nichino Europe to provide more plant health solutions to UK and Ireland

• AgriTrade News – Interagro tag archive (2020–2025) and the 14 April 2023 acquisition article

• Agriculture & Arable Farmer (aafarmer.co.uk) – acquisition; Utrecht office; Heywood, Sutherland and Ferrie appointments

• Hortidaily – Interagro Netherlands B.V. / Utrecht office

• FarmingUK – Great Notley office move; Ramsay and Ralph appointments

• Origin Enterprises / Business & Finance – Emma Ralph appointment (2025)

• Rudlin Consulting – Nihon Nohyaku's first acquisition in Europe

• Cérience – Cantor and Pentra product pages and March 2026 label PDF

• interagro.co.uk – legacy company website

• CPM Magazine – Kantor, Backrow and Toil articles

• LAMMA Show – Nichino Europe exhibitor page (2026)

• PotatoPro – InterAgro directory entry

• stockanalysis.com; envalith.com; FilingReader; Google Finance – Nihon Nohyaku (TSE 4997) data

• EDINET DB – Nihon Nohyaku annual securities report (history)

• Straits Research, IMARC, Mordor Intelligence, Fortune Business Insights, Research & Markets, Technavio – adjuvant market estimates

Verifiable Interagro-specific news in this window is limited because the business had been absorbed into Nichino Europe. The register includes parent-level items where they directly affect the Interagro business. Fewer than 25 entries could be verified.

Earlier context just outside the window: * Emma Ralph's departure (31 Dec 2024; joined Origin 3 Feb 2025); Sarah Ferrie and Stuart Sutherland join De Sangosse (17 Mar 2025); GOZAI and KABUKI UK launch (Jan 2025).